Research Topic · Peer-Reviewed

Heterologous Vaccine

A heterologous vaccine is a type of vaccine in which components of a different species are combined with the active component of the targeted species. They are used to create vaccines against microbes that are difficult to cultivate in a laboratory. By combining the active components of other species, they can enhan…

📚 0 peer-reviewed articles cited 🔖 ISSN 2691-8862 🗓 Reviewed June 2026

Overview

A heterologous vaccine is a type of vaccine in which components of a different species are combined with the active component of the targeted species. They are used to create vaccines against microbes that are difficult to cultivate in a laboratory. By combining the active components of other species, they can enhance the body’s immune reaction and provide greater protection against the targeted microbe. The use of heterologous vaccines can be particularly beneficial in situations where the targeted microbe could be deadly and traditional vaccines have proven ineffective. Heterologous vaccines also have potential applications in cancer therapy and may be used to treat autoimmune diseases.

Research published in this journal

No peer-reviewed research on this exact topic has been published in Current Viruses and Treatment Methodologies yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in Current Viruses and Treatment Methodologies (ISSN 2691-8862).

Journal editorial board
Dr. Anantha Harijith · United States

This page summarises published research for orientation; it is not medical or professional advice.